INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (INO)

Q: What does CUSIP 45773H409 represent in this 13F holders report?

CUSIP 45773H409 is the security identifier for INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q2 2025?

101 institutional investors reported INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 45773H409

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 72,491,935
Total 13F shares: 10,168,502
Share change: -3,439,291
Total reported value: $20,694,831
Put/Call ratio: 30%
Price per share: $2.04
Number of holders: 101
Value change: -$6,577,397
Number of buys: 46
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 45773H409:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13D/G	—	9.2%	3,633,333	$6,794,333	$0	31 Dec 2024	13D/G
Deep Track Capital, LP	13F	Company	4.3%	3,119,162	$5,084,234	—	31 Mar 2025	13F
BlackRock, Inc.	13F 13D/G	Company	1.5% from 13D/G	2,318,480	$3,779,123	—	31 Mar 2025	13F 13D/G
VANGUARD GROUP INC	13F	Company	2.8%	2,028,960	$3,307,206	—	31 Mar 2025	13F
Stonepine Capital Management, LLC	13D/G 13F	Company	3.8%	1,434,997	$2,683,444	-$900,721	31 Mar 2025	13D/G 13F
Jong Joseph Kim	3/4/5	Chief Executive Officer, Director	— mixed-class rows	3,113,086 mixed-class rows	$2,451,149	—	11 Mar 2022	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	1.8%	1,304,987	$2,127,130	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	846,803	$1,380,493	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.71%	514,148	$838,061	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.64%	465,778	$759,219	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.39%	284,643	$463,970	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.29%	207,867	$338,823	—	31 Mar 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.27%	194,371	$316,825	—	31 Mar 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	130,534	$212,770	—	31 Mar 2025	13F
GMT CAPITAL CORP	13F	Company	0.17%	126,119	$205,574	—	31 Mar 2025	13F
Nuveen, LLC	13F	Company	0.14%	103,297	$168,374	—	31 Mar 2025	13F
FMR LLC	13F	Company	0.14%	100,675	$164,101	—	31 Mar 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.14%	98,495	$160,547	—	31 Mar 2025	13F
Bank of New York Mellon Corp	13F	Company	0.1%	75,422	$122,939	—	31 Mar 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.1%	73,575	$119,926	—	31 Mar 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.1%	72,364	$117,953	—	31 Mar 2025	13F
XTX Topco Ltd	13F	Company	0.09%	66,169	$107,855	—	31 Mar 2025	13F
Green Alpha Advisors, LLC	13F	Company	0.08%	61,261	$99,855	—	31 Mar 2025	13F
SEI INVESTMENTS CO	13F	Company	0.08%	56,806	$92,594	—	31 Mar 2025	13F
Concurrent Investment Advisors, LLC	13F	Company	0.08%	55,011	$89,668	—	31 Mar 2025	13F
BANK OF MONTREAL /CAN/	13F	Company	0.06%	46,836	$76,343	—	31 Mar 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	45,828	$74,700	—	31 Mar 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.06%	43,142	$70,321	—	31 Mar 2025	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	41,699	$67,958	—	31 Mar 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.06%	40,456	$66,101	—	31 Mar 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	39,025	$63,610	—	31 Mar 2025	13F
BARCLAYS PLC	13F	Company	0.05%	36,409	$59,347	—	31 Mar 2025	13F
CIBC Private Wealth Group LLC	13F	Company	0.06%	40,000	$58,400	—	31 Mar 2025	13F
Simon X. Benito	3/4/5	Director	— mixed-class rows	17,275 mixed-class rows	$51,120	—	21 May 2025	3/4/5
Prime Capital Investment Advisors, LLC	13F	Company	0.04%	30,299	$49,387	—	31 Mar 2025	13F
Wendy L. Yarno	3/4/5	Director	— mixed-class rows	15,596 mixed-class rows	$47,980	—	21 May 2025	3/4/5
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.04%	29,375	$47,881	—	31 Mar 2025	13F
Ann C. Miller	3/4/5	Director	— mixed-class rows	14,961 mixed-class rows	$46,792	—	21 May 2025	3/4/5
Jay Shepard	3/4/5	Director	— mixed-class rows	14,293 mixed-class rows	$45,543	—	21 May 2025	3/4/5
Roger D. Dansey	3/4/5	Director	— mixed-class rows	14,000 mixed-class rows	$44,995	—	21 May 2025	3/4/5
Lota S. Zoth	3/4/5	Director	— mixed-class rows	13,810 mixed-class rows	$44,640	—	21 May 2025	3/4/5
CITIGROUP INC	13F	Company	0.03%	25,042	$40,819	—	31 Mar 2025	13F
Vanguard Personalized Indexing Management, LLC	13F	Company	0.03%	24,207	$39,457	—	31 Mar 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	22,369	$36,462	—	31 Mar 2025	13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13F	Company	0.03%	20,781	$33,873	—	31 Mar 2025	13F
Freedom Investment Management, Inc.	13F	Company	0.03%	19,170	$31,247	—	31 Mar 2025	13F
INTECH INVESTMENT MANAGEMENT LLC	13F	Company	0.03%	18,441	$30,059	—	31 Mar 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.02%	18,000	$29,340	—	31 Mar 2025	13F
Corebridge Financial, Inc.	13F	Company	0.02%	17,708	$28,864	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	17,631	$28,738	—	31 Mar 2025	13F

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (INO) as of Q2 2025

As of 30 Jun 2025, INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (INO) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,168,502 shares. The largest 10 holders included VANGUARD GROUP INC, Deep Track Capital, LP, BANK OF AMERICA CORP /DE/, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and UBS Group AG. This page lists 102 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

105

Q2 2025 holders

101

Holder diff

-4

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.